Diagnostic p53 expression in gastric endoscopic mucosal resection

Journal of Korean Medical Science

Volumn 14, Issue 4, 1999, Pages 412-416

  Cho, Jeong Hee ^a   Roe, Im Hwan ^a   Jin, Young Joo ^a  

^a Dankook University   (South Korea)

Author keywords

Adenoma, gastric; Early gastric carcinoma; Immunohistochemistry; Protein p53; Surgical procedure, endoscopic, mucosal resection

Indexed keywords

DIAGNOSTIC AGENT; PROTEIN P53; TUMOR MARKER;

ADENOCARCINOMA; ADENOMA; ARTICLE; BIOSYNTHESIS; CHEMISTRY; ENDOSCOPY; ENZYME IMMUNOASSAY; HUMAN; METABOLISM; PATHOLOGY; STOMACH MUCOSA; STOMACH TUMOR;

ADENOCARCINOMA; ADENOMA; ENDOSCOPY; GASTRIC MUCOSA; HUMANS; IMMUNOENZYME TECHNIQUES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033173373     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1999.14.4.412     Document Type: Article

References (17)

1. Inoue H. Endoscopic mucosal resection for esophageal and gastric mucosal cancers. Can J Gastroenterol 1998; 12: 355-9.
2. Hosokawa K, Yoshida S. Recent advances in endoscopic mucosal resection for early gastric cancer. Gan To Kagaku Ryoho 1998; 25: 476-83.
3. Korenaga D, Orita H, Maekawa S, Maruoka A, Sakai K, Ikeda T, Sugimachi K. Pathological appearance of the stomach after endoscopic mucosal resection for early gastric cancer. Br J Surg 1997; 84: 1563-6.
4. Lauren P. The two histological main types of gastric carcinoma; diffuse and so-called intestinal-type carcinoma. An attempt at histochemical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
5. Sturzbecher HW, Brain R, Addison C, Rudege K, Remm M, Grimaldi M, Keenan E, Jenkins JR. A C-terminal alpha helix plus basic motif is the major structural determinant of p53 tetramerization. Oncogene 1992: 1513-23.
6. Reich NC, Levine AJ. Growth regulation of a cellular tumor antigen, p53, in nontransformed cells. Nature 1984; 308: 199-201.
7. Finlay CA, Hinds PW, Tan T-H, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 1988; 8: 531-9.
8. Uchino S, Noguchi M, Hirota T, Itabashi M, Saito T, Kobayashi M, Hirohashi S. High incidence of nuclear accumulation of p53 protein in gastric cancer. Jpn J Clin Oncol 1992; 22: 225-31.
9. Cho JH, Noguchi M, Ochiai A, Uchino S, Hirohashi S. Analysis of regional difference of p53 mutation in advanced gastric carcinoma: relation to heterogeneous differentiation and invasiveness. Mod Pathol 1994; 7: 205-11.
10. Cho JH, Kim WH. Altered topographic expression of p21WAF1/CIP1/SD11, bcl2, p53 during gastric carcinogenesis. Pathol Res Pract 1998; 194: 309-17.
11. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S. p53 mutation in gastric cancer; a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 1993; 54: 759-64.
12. Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993; 119: 1-8.
13. Cho JH, Noguchi M, Ochiai A, Hirohashi S. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction. Lab Invest 1996; 74: 835-41.
14. Pennie JS, Jackqueline ML, Maria JB, Filip MI. p53 expression in Barretts esophagus, dysplasia, and adenocarcinoma using antibody DO-7. J Pathol 1994; 173: 221-6.
15. Feron ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987; 238: 193-7.
16. Ponder BAJ, Wilkinson MM. Direct examination of the clonality of carcinogen-induced colonie epithelial dysplasia in chimeric mice. J Natl Cancer Inst 1986; 77: 967-76.
17. Wynford-Thomas D. p53 in tumor pathology: can we trust immunocytochemistry? J Pathol 1992; 166: 329-30.